Enzymotec Ltd. Responds to Unsolicited Proposal from Frutarom Ltd.
Aug 28, 2017 12:30 pm UTC| Business
MIGDAL HA’EMEQ, Israel, Aug. 28, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY) today responded to the unsolicited proposal from Frutarom Ltd. to acquire Enzymotec for $11.50 per share by sending the below letter to Frutarom...
Aug 28, 2017 12:30 pm UTC| Business
SAN JOSE, Calif., Aug. 28, 2017 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, is pleased to announce the availability of its Glassware 2.0® (Glassware)...
Sphere 3D Introduces New Datrium Ready Nodes for the Open Software Defined Data Center
Aug 28, 2017 12:30 pm UTC| Business
SAN JOSE, Calif., Aug. 28, 2017 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, is pleased to announce the availability of Sphere 3D’s new HVE Datrium Ready...
Aug 28, 2017 12:30 pm UTC| Business
SAN JOSE, Calif., Aug. 28, 2017 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, is pleased to announce the introduction of a new HVE branded HyperConverged...
Aug 28, 2017 12:30 pm UTC| Business
US Patent Office has Published Patent Application for M207 Zolmitriptan Delivered Intracutaneously via Zosano’s Proprietary Adhesive Dermally-Applied Microarray (ADAM) Technology FREMONT, Calif., Aug. 28, 2017 --...
Aug 28, 2017 12:30 pm UTC| Business
REDWOOD CITY, Calif., Aug. 28, 2017 -- Coherus BioSciences, Inc. (NASDAQ:CHRS), today reported topline results from the first of three ongoing pharmacokinetic bioequivalence (“PK/BE”) studies comparing CHS-1420, a...
Aug 28, 2017 12:30 pm UTC| Business
Trend toward preservation of renal function (eGFR) in blisibimod treated patientsLack of disease progression, as measured by proteinuria in blisibimod treated patients HAYWARD, Calif., Aug. 28, 2017 -- Anthera...